Follow Us On
Tablet
Files
Valganciclovir
Strength: 450mg
Count: 60
NDC
42291-973-60
Class
Rx
Brand Name
Valcyte Tablets
Imprint Code
E114
Color(s)
PINK
Shape
Oval
Score
No Score
Case Count
NA
Inactive Ingredients
colloidal silicon dioxide, crospovidone, microcrystalline cellulose, povidone K-30, and stearic acid. The film-coat applied to the tablets contains polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide red
Indications and Usage
1.1 Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis: Valganciclovir Tablets, USP are indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Prevention of CMV Disease: Valganciclovir Tablets, USP are indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-]). 1.2 Pediatric Patients Prevention of CMV Disease: Valganciclovir Tablets, USP are indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk.
